These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1700586

  • 1. [Study on the concentration of cefminox sodium in serum and prostatic tissue].
    Sasagawa I.
    Hinyokika Kiyo; 1990 Jun; 36(6):737-9. PubMed ID: 1700586
    [Abstract] [Full Text] [Related]

  • 2. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
    Takao M, Matsuzaki S, Ao T, Nagakura K, Fujioka T, Hata M, Nakamura H, Hayakawa M.
    Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
    [Abstract] [Full Text] [Related]

  • 3. Cefminox sodium penetration into prostatic tissue with and without inflammation.
    Sasagawa I, Yamaguchi O, Shiraiwa Y.
    Int Urol Nephrol; 1991 Mar; 23(6):569-72. PubMed ID: 1722784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prostatic tissue levels of cefpiramide (CPM)].
    Takata K, Kawamura S, Yoshida I.
    Hinyokika Kiyo; 1988 Jun; 34(6):1105-8. PubMed ID: 2464916
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Study of the prostatic tissue cefbuperazone (CBPZ) level].
    Fjuii H, Niibori D, Okamura K, Hashimoto H, Tokunaka S, Yachiku S, Osanai H.
    Hinyokika Kiyo; 1988 May; 34(5):932-6. PubMed ID: 2459941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M, Hatakeyama T, Suzuki K.
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [Abstract] [Full Text] [Related]

  • 11. [Serum and prostatic tissue concentration of ceftizoxime (CZX) after intravenous administration in cases of benign prostatic hypertrophy].
    Wakatsuki A, Nishio S, Morita M, Takeuchi M, Murase M.
    Hinyokika Kiyo; 1985 Nov; 31(11):2080-4. PubMed ID: 2418663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.